4//SEC Filing
Collins Tony W. 4
Accession 0000911916-17-000222
CIK 0001136869other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:35 PM ET
Size
28.9 KB
Accession
0000911916-17-000222
Insider Transaction Report
Form 4
Collins Tony W.
VP, Controller and CAO
Transactions
- Exercise/Conversion
Common Stock
2017-07-31$94.34/sh+2,428$229,058→ 5,224 total - Exercise/Conversion
Common Stock
2017-07-31$73.15/sh+1,752$128,159→ 2,796 total - Exercise/Conversion
Common Stock
2017-07-31$104.01/sh+2,670$277,707→ 17,340 total - Sale
Common Stock
2017-07-31$121.76/sh−93$11,324→ 951 total - Exercise/Conversion
Employee Stock Option (right to buy)
2017-07-31−4,723→ 4,723 totalExercise: $113.83Exp: 2025-06-24→ Common Stock (4,723 underlying) - Exercise/Conversion
Common Stock
2017-07-31$113.83/sh+4,723$537,619→ 9,947 total - Sale
Common Stock
2017-07-31$122.38/sh−1,200$146,855→ 1,044 total - Sale
Common Stock
2017-07-31$121.32/sh−597$72,428→ 354 total - Exercise/Conversion
Employee Stock Option (right to buy)
2017-07-31−2,428→ 1,213 totalExercise: $94.34Exp: 2024-03-17→ Common Stock (2,428 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2017-07-31−4,723→ 4,722 totalExercise: $113.83Exp: 2025-06-24→ Common Stock (4,723 underlying) - Exercise/Conversion
Common Stock
2017-07-31$113.83/sh+4,723$537,619→ 14,670 total - Sale
Common Stock
2017-07-31$121.71/sh−15,096$1,837,327→ 2,244 total - Exercise/Conversion
Employee Stock Option (right to buy)
2017-07-31−1,752→ 0 totalExercise: $73.15Exp: 2023-03-18→ Common Stock (1,752 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2017-07-31−2,670→ 8,010 totalExercise: $104.01Exp: 2026-03-21→ Common Stock (2,670 underlying)
Footnotes (8)
- [F1]Includes 120 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between May 1, 2017 and June 30, 2017.
- [F2]Represents the sale of 15,096 shares in multiple transactions ranging in price from $121.15 to $122.14 per share, resulting in a weighted average sale price of $121.7095. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- [F3]Represents the sale of 1,200 shares in multiple transactions ranging in price from $122.16 to $122.52 per share, resulting in a weighted average sale price of $122.3792. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- [F4]The options vested on March 18, 2017.
- [F5]1,214 options vested on each of March 17, 2016 and 2017; and the remaining 1,213 of the options are scheduled to vest on March 17, 2018.
- [F6]2,362 options vested on June 24, 2016; 2,361 options vested on June 24, 2017; and the remaining options will vest as to 2,361 options on each of June 24, 2018 and 2019.
- [F7]2,362 options vested on June 24, 2016; 2,361 options vested on June 24, 2017; and the remaining options will vest as to 2,362 options on June 24, 2018 and as to 2,361 options on June 24, 2019.
- [F8]2,670 options vested on March 21, 2017; and the remaining options will vest as to 2,670 options on each of March 21, 2018, 2019 and 2020.
Documents
Issuer
ZIMMER BIOMET HOLDINGS, INC.
CIK 0001136869
Entity typeother
Related Parties
1- filerCIK 0001636683
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 4:35 PM ET
- Size
- 28.9 KB